NCT01724034

Brief Summary

Daily lung ultrasound can help weaning from mechanical ventilation in difficult-to-wean adult patients. In this randomized trial, standardized lung ultrasound will be performed daily asssociated with standardized interventions aiming to decrease the total time in mechanical ventilation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
128

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2012

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 5, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 9, 2012

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
Last Updated

November 9, 2012

Status Verified

November 1, 2012

Enrollment Period

1.2 years

First QC Date

November 5, 2012

Last Update Submit

November 6, 2012

Conditions

Keywords

WeaningMechanical VentilationLung Ultrasound

Outcome Measures

Primary Outcomes (1)

  • Time in mechanical ventilation

    from intubation until extubation success (defined as weaning from mechanical support for, at least, 48 hours) or death (days)

Secondary Outcomes (7)

  • Number of tracheostomies performed

    patients follow-up will continue until weaning from mechanical support, up to 2 months

  • Length of ICU stay

    from icu admition until icu discharge, up to 2 months

  • Incidence of ventilation-associated pneumonia

    until icu discharge, up to 2 months

  • ICU's, Hospital's and 28-days mortality

    until ICU's and hospital's discharge and 28th day from ICU admisson, with an expected average of 4 weeks

  • Performance status at ICU's and Hospital's discharge

    at icu's and hospital discharge, with an expected average of 4 weeks

  • +2 more secondary outcomes

Study Arms (2)

Daily Lung Ultrasound

EXPERIMENTAL

If there is no lung sliding - evaluation for pneumothorax or mainstream intubation. If lung ultrasound shows normal pattern - search for reversible airway obstruction or venous embolism. If the patient has COPD, non invasive ventilation must be used as mode of discontinuing mechanical ventilation. If lung ultrasound shows intersticial syndrome - evaluate the need to negativate hydric balance before the next spontaneous breathing trial. If findings are asymmetrical - search for new or uncontrolled infection. If there is simple pleural effusion - researchers should determine a negativation of hydric balance or perform thoracocentesis. If there are signs of complicated pleural effusion - a new image technique should be performed as evaluated by the surgical team.

Other: Abolish Lung SlidingOther: Normal Lung UltrasoundOther: Pulmonary Interstitial SyndromeOther: Asymmetrical Lung UltrasoundOther: Simple Pleural EffusionOther: Complex Pleural Effusion

Control Group

NO INTERVENTION

Interventions

If there is no lung sliding, the patient will be promptly evaluated for pneumothorax or mainstream intubation.

Daily Lung Ultrasound

If the patient fails the spontaneous breathing trial and the lung ultrasound examination is normal - researchers will investigate venous thrombosis (deep vein thrombosis and/or pulmonary embolism) and rule out reversible airway obstruction. If the patient has the previous diagnosis of COPD, non invasive mechanical ventilation is indicated for facilitate weaning.

Daily Lung Ultrasound

If lung ultrasound shows "B pattern" - cardiogenic pulmonary edema will be differentiated from Acute Respiratory Distress Syndrome (ARDS). If cardiogenic edema is a possibility, diuretics will be administrated (at least 40 mg of furosemide) or ultrafiltration will be performed. The main target is a negative fluid balance of, at least, 1000 ml before the next spontaneous breathing trial. Another possibility is to titrate vasodilators (at least a 20% reduction in the systolic blood pressure) before the next spontaneous breathing trial.

Also known as: B Lines
Daily Lung Ultrasound

If lung ultrasound shows asymmetrical findings, the occurence of new or uncontrolled infection (pulmonary or extrapulmonary) will be investigated.

Also known as: AB Profile or Consolidation
Daily Lung Ultrasound

If the patient has pleural effusion without ultrasonographic signs of complications (any hyperechoic pattern or complex septated pattern), researchers will administrate diuretics (at least 40 mg of furosemide in 24 hours) or increase ultrafiltration - to achieve a negative fluid balance of, at least, 1000 ml before the next spontaneous breathing trial. Another possibility is to perform pleural drainage.

Daily Lung Ultrasound

If there is pleural effusion with hyperechoic or septated pattern, another image exam will be performed and evaluated by the surgical team.

Daily Lung Ultrasound

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Difficult to Wean;
  • failure in the spontaneous breathing trial or 1 extubation failure
  • Adult patients (over 18 years old);

You may not qualify if:

  • Palliative Care;
  • Life expectancy under 90 days;
  • COPD Gold IV, Cirrhosis Child C, Metastatic Cancer with low performance, etc
  • Other weaning method than institutional protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Ernesto Dornelles

Porto Alegre, Rio Grande do Sul, 90160-093, Brazil

RECRUITING

Study Officials

  • Felippe L Dexheimer, MD

    Hospital Ernesto Dornelles

    PRINCIPAL INVESTIGATOR
  • Cassiano Teixeira, MD, PhD

    Hospital Moinhos de Vento

    STUDY CHAIR
  • Paulo R Dalcin, MD, PhD

    Federal University of Rio Grande do Sul

    STUDY DIRECTOR

Central Study Contacts

Felippe L Dexheimer Neto, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D.

Study Record Dates

First Submitted

November 5, 2012

First Posted

November 9, 2012

Study Start

October 1, 2012

Primary Completion

December 1, 2013

Study Completion

June 1, 2014

Last Updated

November 9, 2012

Record last verified: 2012-11

Locations